UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 9, 2013

 

 

THE DOW CHEMICAL COMPANY

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   1-3433   38-1285128

(State or other jurisdiction

of incorporation)

 

(Commission

file number)

 

(I.R.S. Employer

Identification No.)

 

2030 DOW CENTER,

MIDLAND, MICHIGAN

  48674
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: 989-636-1000

Not applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.07 Submission of Matters to a Vote of Security Holders.

The Annual Meeting of Stockholders of the Company was held on May 9, 2013 for the purposes of (i) electing 10 directors to hold office until the next annual meeting of stockholders; (ii) ratifying the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the 2013 fiscal year; (iii) holding an advisory vote on executive compensation; and (iv) holding a vote on one stockholder proposal.

All of management’s nominees for director as named in the Company’s Proxy Statement were elected by the votes set forth in the table below.

Election of Directors.

 

     Votes For      Votes Against      Abstentions     
Broker Non-
Votes
 

Arnold A. Allemang

     881,247,284         25,659,208         5,967,852         134,667,739   

Ajay Banga

     883,397,898         21,949,527         7,526,919         134,667,739   

Jacqueline K. Barton

     883,159,274         23,249,808         6,465,262         134,667,739   

James A. Bell

     885,939,104         19,999,348         6,935,892         134,667,739   

Jeff M. Fettig

     880,097,792         26,002,965         6,773,587         134,667,739   

Andrew N. Liveris

     869,173,750         36,268,912         7,431,682         134,667,739   

Paul Polman

     883,054,865         22,440,356         7,379,123         134,667,739   

Dennis H. Reilley

     881,437,596         24,226,890         7,209,858         134,667,739   

James M. Ringler

     792,557,234         113,229,109         7,088,001         134,667,739   

Ruth G. Shaw

     811,073,937         94,861,362         6,939,045         134,667,739   

The appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the 2013 fiscal year was ratified by the votes set forth in the table below.

 

     Votes For      Votes Against      Abstentions     
Broker Non-
Votes
 

Ratification of independent registered public accounting firm

     1,023,194,780         17,736,130         6,611,173         N/A   

The Company’s executive compensation was approved, on an advisory basis, by the votes set forth in the table below.

 

     Votes For      Votes Against      Abstentions      Broker Non-
Votes
 

Advisory vote on executive compensation

     675,839,201         225,861,102         11,174,041         134,667,739   


The stockholder proposal on shareholder action by written consent was defeated, by the votes set forth in the table below.

 

     Votes For      Votes Against      Abstentions      Broker Non-
Votes
 

Stockholder proposal on executive stock retention

     181,584,291         718,979,848         12,310,205         134,667,739   


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

            THE DOW CHEMICAL COMPANY            

Registrant

Date: May 14, 2013

 

/s/ CHARLES J. KALIL

Charles J. Kalil

Executive Vice President, General

Counsel and Corporate Secretary